Geller Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-978
Closed -$314K 273
2024
Q2
$314K Buy
978
+22
+2% +$7.15K 0.02% 199
2024
Q1
$319K Buy
956
+3
+0.3% +$917 0.03% 199
2023
Q4
$258K Sell
953
-43
-4% -$10.6K 0.03% 221
2023
Q3
$245K Buy
996
+28
+3% +$7.66K 0.03% 218
2023
Q2
$294K Sell
968
-164
-14% -$45.6K 0.04% 187
2023
Q1
$298K Buy
1,132
+184
+19% +$46.7K 0.04% 121
2022
Q4
$227K Buy
+948
New +$212K 0.04% 136
2022
Q2
Sell
-933
Closed -$234K 150
2022
Q1
$234K Buy
+933
New +$234K 0.04% 140

Other funds holding HCA

Geller Advisors's HCA Position: Q3 2024 in Review

Geller Advisors sold out of HCA Healthcare (HCA) in Q3 2024, closing a stake of 978 shares — an estimated $314K sold.

Geller Advisors first reported a position in HCA in Q1 2022 and held it in 8 quarters. The position peaked at $319K in Q1 2024. 1,202 funds tracked by Wall St. Rank hold HCA as of Q3 2024.

  • Geller Advisors reported no remaining HCA Healthcare position as of Q3 2024 after selling out during the quarter.
  • Geller Advisors sold 978 HCA Healthcare shares in Q3 2024, an estimated $314K.
  • Geller Advisors first reported a position in HCA Healthcare in Q1 2022 and held it in 8 quarters.
  • Geller Advisors's HCA Healthcare position peaked at $319K in Q1 2024.
  • 1,202 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2024.

Based on Geller Advisors's 13F filing for Q3 2024, filed 15 Nov 2024.